ECETOC florence workshop on risk assessment of endocrine substances, including the potency concept

Toxicology Letters

Volumn 223, Issue 3, 2013, Pages 310-314

  Fegert, Ivana ^a  

^a BASF SE   (Germany)

Author keywords

ECETOC proposal; Endocrine disruption; Risk assessment

Indexed keywords

ENDOCRINE DISRUPTOR; THYROID HORMONE;

ARTICLE; CONCEPTUAL FRAMEWORK; DISEASE PREDISPOSITION; ECOTOXICITY; ENDOCRINE FUNCTION; ENDOCRINE SYSTEM; ENDOCRINE TOXICITY; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HORMONE RECEPTOR INTERACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID FUNCTION; TOXIC INHALATION; TOXICITY; VAPOR; WILDLIFE; WORKSHOP;

ECETOC PROPOSAL; ENDOCRINE DISRUPTION; RISK ASSESSMENT;

ANIMALS; ANIMALS, WILD; DECISION TREES; DISINFECTANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ECOTOXICOLOGY; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; EUROPEAN UNION; EVIDENCE-BASED PRACTICE; GUIDELINES AS TOPIC; HUMANS; INTERNATIONAL AGENCIES; LEGISLATION, DRUG; PESTICIDES; RISK ASSESSMENT; TERMINOLOGY AS TOPIC;

EID: 84888047624     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.03.027     Document Type: Article

References (11)

1. Alison R.H., Capen C.C., Prentice D.E. Neoplastic lesions of questionable significance to humans. Toxicologic Pathology 1994, 22:179-186.
2. Ames B.N., Magaw R., Gold L.S. Ranking possible carcinogenic hazards. Science 1987, 236:271-280.
3. Bars R., Broeckaert F., Fegert I., Gross M., Hallmark N., Kedwards T., Lewis D., O'Hagan S., Panter H.G., Weltje L., Weyers A., Wheeler J.R., Galay-Burgos M. Science based guidance for the assessment of endocrine disrupting properties of chemicals. Regulatory Toxicology and Pharmacology 2011, 59:37-46.
4. Bars R., Broeckaert F., Fegert I., Gross M., Hallmark N., Kedwards T., Lewis D., O'Hagan S., Panter H.G., Weltje L., Weyers A., Wheeler J.R., Galay-Burgos M. Corrigendum to "Science based guidance for the assessment of endocrine disrupting properties of chemicals" [Regul Toxicol. Pharmacol. 59 (2011) 37-46]. Regulatory Toxicology and Pharmacology 2011, 60:411-412.
5. BfR (Bundesinstitut für Risikobewertung), 2011. Final Joint DE-UK position. Regulatory definition of an endocrine disrupter in relation to potential threat to human health. Available at: (accessed 08.07.11). http://www.bfr.bund.de/cm/349/regulatory_definition_of_an_endocrine_disrupter_in_relation_to_potential_threat_to_human_health.pdf.
6. Boobis A.R., Cohen S.M., Dellarco V., McGregor D., Meek M.E., Vickers C., Willcocks D., Farland W. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Critical Reviews in Toxicology 2006, 36:781-792.
7. Boobis A.R., Doe J.E., Heinrich-Hirsch B., Meek M.E., Munn S., Ruchirawat M., Schlatter J., Seed J., Vickers C. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Critical Reviews in Toxicology 2008, 38:87-96.
8. ECETOC, 2009a. Guidance on identifying endocrine disrupting effects. Technical Report No. 106. Brussels. ISSN-0773-8072-106. Available at: http://bit.ly/ecetoc-tr106.
9. ECETOC, 2009b. Workshop: guidance on identifying endocrine disrupting effects, 29-30 June 2009, Barcelona. Workshop Report No. 16. Brussels. Available at: http://bit.ly/ecetoc-wr16.
10. ECETOC, 2011. Risk assessment of endocrine disrupting chemicals, 9-10 May, 2011, Florence. Workshop Report No. 21. Brussels. ISSN- 2078-7200-21. Available at http://bitly/ecetoc-wr21.
11. Lewis R.W. Risk assessment of 'endocrine substances': Guidance on identifying endocrine disruptors. Risk Assessment of Endocrine Disrupting Chemicals 2013, 223:287-290.